order now  (800) 873-5141


Medical Food Designed to
Protect Optic Nerve Cells from

Damage and Death in
Glaucoma Patients

Click here to resize type

References

Mitochondrial dysfunction in Glaucoma:

Huang, C., Lin, Y., Huang, Y., & Tsai, F. (2020). Mitochondrial Dysfunction as a Novel Target for Neuroprotective Nutraceuticals in Ocular Diseases. Nutrients, 12(7):1950. doi: 10.3390/nu12071950

Pinazo-Durán, M., Zanón-Moreno, V., Gallego-Pinazo, R., & García-Medina, J. (2015). Oxidative stress and mitochondrial failure in the pathogenesis of glaucoma neurodegeneration. Prog Brain Res., 220:127-153. doi: 10.1016/bs.pbr.2015.06.001

Osborne, N., Álvarez, N., & Aguado, S. (2014). Targeting mitochondrial dysfunction as in aging and glaucoma. Drug Discov Today, 19(10):1613-1622. doi:10.1016/j.drudis.2014.05.010

Lascaratos, G., Garway-Heath, D., Willoughby, C., Chau, K., & Schapira, A. (2011). Mitochondrial dysfunction in glaucoma: Understanding genetic influences. Mitochondrion, 12(2):202-212. doi: 10.1016/j.mito.2011.11.004

Kong, G., Van, N., Trounce, I., & Crowston, J. (2009). Mitochondrial Dysfunction and Glaucoma. Journal of Glaucoma, 18(2):93-100. doi: 10.1097/IJG.0b013e318181284f

 

Neurodegenerative disease:

Gauthier, A., & Liu, J. (2016). Neurodegeneration and Neuroprotection in Glaucoma. The Yale journal of biology and medicine, 89:73-79. Retrieved from: https://medicine.yale.edu/yjbm/

Gupta, N., & Yücel, Y. (2007). Glaucoma as a neurodegenerative disease. Curr Opin Ophthalmol., 18(2):110-114. doi: 10.1097/ICU.0b013e3280895aea

 

Ingredients Support:

Wang, L., Sun, Y., Huang, K., & Zheng, L. (2013). Curcumin, a potential therapeutic candidate for retinal diseases. Mol NutrFood Res, 57(9):1557-1568. doi: 10.1002/mnfr.201200718

Chrysostomou, V., Rezania, F., Trounce, I., & Crowston, G. (2013). Oxidative stress and mitochondrial dysfunction in glaucoma. Curr Opin Pharmacol., 13(1):12-15. doi:10.1016/j.coph.2012.09.008

Williams, P., Harder, J., & John, S. (2017). Glaucoma as a Metabolic Optic Neuropathy: Making the Case for Nicotinamide Treatment in Glaucoma. J Glaucoma, 26(12):1161-1168. doi:10.1097/IJG.0000000000000767

Quaranta, L., Bettelli, S., Uva, M., Semeraro, F., Turano, R., & Gandolfo, E. (2003). Effect of Ginkgo biloba extract on preexisting visual field damage in normal tension glaucoma. Ophthalmology, 110(2):359-362. doi: 10.1016/S0161-6420(02)01745-1

Filina, A., Davydova, N., Endrikhovskiĭ, S., & Shamshinova, A. (1995). Lipoic acid as a means of metabolic therapy of open-angle glaucoma. Vestn Oftalmol, 111(4):6-8. Retrieved from https://www.mediasphera.ru/journal/vestnik-oftalmologii

Parisi, V., Manni, G., Colacino, G., & Bucci, M. (1999). Cytidine-5′-diphosphocholine (citicoline) improves retinal and cortical responses in patients with glaucoma. Ophthalmology, 106(6):1126-1134. doi:10.1016/S0161-6420(99)90269-5

Yang H, Lee BK, Kook KH, Jung YS, Ahn J. (2012). Protective effect of grape seed extract against oxidative stress-induced cell death in a staurosporine-differentiated retinal ganglion cell line. Curr Eye Res., 37(4):339-344. doi:10.3109/02713683.2011.645106

Yang, S., Lee, B., & Koh, J. (2007). Protective effects of epigallocatechin gallate after UV irradiation in cultured human retinal pigment epithelial cells. Korean J Ophthalmol, 21(4):232-237. doi:10.3341/kjo.2007.21.4.232

Tomasetti, M., Alleva, R., Borghi, B., & Collins, A. (2001). In vivo supplementation with coenzyme Q10 enhances the recovery of human lymphocytes from oxidative DNA damage. FASEB J., 15(8):1425-1427. doi:10.1096/fj.00-0694fje

Hytti, M., Piippo, N., Korhonen, E., Honkakoski, P., Kaarniranta, K., & Kauppinen, A. (2015). Fisetin and luteolin protect human retinal pigment epithelial cells from oxidative stress-induced cell death and regulate inflammation. Sci Rep., 5:17645. doi:10.1038/srep17645

Gao, F., Zhang, S., Xu, P., et al. (2017). Quercetin Declines Apoptosis, Ameliorates Mitochondrial Function and Improves Retinal Ganglion Cell Survival and Function in In Vivo Model of Glaucoma in Rat and Retinal Ganglion Cell Culture In Vitro. Front Mol Neurosci., 10:285. doi:10.3389/fnmol.2017.00285

Glaucocetin retinal & neuroprotection medical food
Glaucocetin logo
  • Checkmark

    The Precursor Compound (Glaucohealth™)* was Proven in Clinical Trials, at World-Renowned New York Eye and Ear Infirmary, to Reverse Mitochondrial Dysfunction in Glaucoma Nerve Cells

  • Checkmark

    First Medical Food developed specifically to Reverse Damage to Glaucoma Nerve Cells caused by underlying Mitochondrial Dysfunction

  • Checkmark

    Comes in Powder Form for Maximum Absorption

*The Precursor to GlaucoCetin, Glaucohealth™, and all related formulas created by Dr Robert Ritch were acquired by Guardion Health Sciences in the second quarter of 2018 and subsequently renamed GlaucoCetin.

Glaucocetin medical food patient

Order your 28 day supply Today

GlaucoCetin is the first vision-specific Medical Food designed to support and protect the mitochondrial function of nerve cells in glaucoma patients.

28 Day Supply: Comes in Powder Form. When using auto-ship, the first order includes a hand-held mini-blender.

Doctor Authorization Code (DAC) Number Required

One Time Order
79.95
Buy Now
Auto Delivery *
75.95
Buy Now
* Receive 5% off when you sign up for auto delivery

GlaucoCetin® is a Medical Food. In order to process your order, you will need a DAC (Doctor Authorization Code) number from your healthcare provider. If you do not have a DAC number, please call us at (800) 873-5141 Dial 1 so that we may assist you.

Please use ONLY letters (A-Z) and numbers (0-9) in the “DAC” field on checkout. No space or symbols.

 

Contact us for general inquiries and feedback about GlaucoCetin

=